ISI Group Initiates HCP With Neutral
Analysts at ISI Group initiated coverage on HCP (NYSE: HCP) with a Neutral rating.
The target price for HCP is set to $42.
HCP shares have gained 2.69% over the past 52 weeks, while the S&P 500 index has surged 16.41% in the same period.
HCP's shares rose 0.50% to close at $40.10 on Friday.
Latest Ratings for HCP
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2022 | JMP Securities | Maintains | Market Outperform | |
Jan 2022 | Citigroup | Initiates Coverage On | Neutral | |
Jan 2022 | Wolfe Research | Initiates Coverage On | Outperform |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: ISI GroupInitiation Analyst Ratings